Home › Funds › Cornerstone Capital, Inc. › VKTX
Cornerstone Capital, Inc. position in VKTX
VIKING THERAPEUTICS INC · Health Care
Cornerstone Capital, Inc. reported holding 85,470 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.3M, representing 0.30% of its reported portfolio and ranking #50 among its reported holdings. Cornerstone Capital, Inc. has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cornerstone Capital, Inc.'s VKTX position evolved
Cornerstone Capital, Inc. first disclosed a stake in VKTX in Q3 2023 at 110,145 shares (US$1.2M). The position peaked in Q2 2026 at 85,470 shares, worth US$3.3M. Across 12 filings, Cornerstone Capital, Inc. increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 85,470 shares valued at US$3.3M — a reduction of -1,430 shares quarter over quarter.. Notable position changes include a 69% trim in Q1 2024 (shares fell 35% over the following quarter), a 285% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 110.14K | $1.22M | New |
| Q4 2023 | 109.97K | $2.05M | Hold |
| Q1 2024 | 33.95K | $2.78M | Reduce |
| Q2 2024 | 33.95K | $1.80M | Hold |
| Q3 2024 | 29.77K | $1.88M | Reduce |
| Q4 2024 | 24.80K | $997.95K | Reduce |
| Q1 2025 | 24.28K | $586.36K | Reduce |
| Q2 2025 | 24.28K | $643.42K | Hold |
| Q3 2025 | 22.55K | $592.61K | Reduce |
| Q4 2025 | 22.55K | $793.31K | Hold |
| Q1 2026 | 86.90K | $2.83M | Add |
| Q2 2026 | 85.47K | $3.33M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on Cornerstone Capital, Inc.
FAQ
How long has Cornerstone Capital, Inc. held VKTX?
Cornerstone Capital, Inc. has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Cornerstone Capital, Inc.'s current position in VKTX?
As of Q2 2026, Cornerstone Capital, Inc. holds 85.47K shares of VKTX (VIKING THERAPEUTICS INC), valued at $3.33M, representing 0.30% of its reported portfolio and ranking #50.
Has Cornerstone Capital, Inc. been buying or selling VKTX?
In the latest 13F filing (Q2 2026), Cornerstone Capital, Inc. reduced its position in VKTX. The position peaked in Q2 2026 at 85.47K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.